Strategies for delivery of peptides utilizing absorption-enhancing agents

Journal of Pharmaceutical Sciences
J A Fix

Abstract

The development of oral formulations for the effective delivery of peptides and proteins has been an elusive target. Although some success has been achieved (e.g., with cyclosporine), progress has been slow compared with what has been achieved with more traditional, organic drug molecules. Poor membrane permeability, enzymatic instability, and large molecular size are three factors that have remained major hurdles for peptide formulators. Absorption-enhancing agents that have been effective, at least in research environments, with smaller drug candidates, have also shown some limited efficacy in small animal models with certain peptides. In most cases, however, effective formulations have only achieved fairly low peptide absorption (< 10%) and have also resulted in significant alterations in the normal cellular morphology of the gastrointestinal tract, at least on a transient basis. Both literature and current data are reviewed in this report. Taken as a whole, the data suggest that the successful development of oral peptide formulations remains a significant challenge. Where successes are achieved, they will most likely be on a case-by-case basis and will reflect a balance between absorption-promoting efficacy of the formulati...Continue Reading

References

Apr 1, 1984·The Journal of Pharmacy and Pharmacology·J A FixJ Alexander
Oct 1, 1994·Journal of Pharmaceutical Sciences·J C Scott-MoncrieffA K Mitra
Aug 1, 1994·Pharmaceutical Research·E S SwensonW Curatolo

❮ Previous
Next ❯

Citations

Mar 21, 2000·Medicinal Research Reviews·A Leone-BayJ J Weidner
Sep 9, 2011·Journal of Materials Science. Materials in Medicine·Menemşe GümüşderelioğluT Tolga Demirtaş
Jan 15, 2005·Pharmaceutical Research·Xuan DingJoseph R Robinson
Apr 11, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·F A DorkooshH E Junginger
May 31, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Farid A DorkooshHans E Junginger
Mar 23, 1999·British Journal of Haematology·A AntonelliM Magnani
Nov 23, 2011·The AAPS Journal·Bruce J Aungst
Jan 14, 1999·Journal of Drug Targeting·R KingetG van den Mooter
Oct 6, 2009·Advanced Drug Delivery Reviews·Sam MaherDavid J Brayden
Nov 19, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·A M M SadeghiH E Junginger
Aug 25, 2004·The Journal of Pharmacy and Pharmacology·Chun-Lei Li, Ying-Jie Deng
Mar 19, 2009·Journal of Clinical Pharmacology·Carol M MacLeanChristoph Beglinger
Oct 2, 2001·The Journal of Pharmacy and Pharmacology·C WestbergB Sjöström
Mar 29, 2000·Journal of Pharmaceutical Sciences·B J Aungst
Aug 10, 2004·Journal of Occupational and Environmental Medicine·Daniel A GoldsteinB Rodrigo Cabanilla
Apr 2, 2003·Nature Reviews. Drug Discovery·Michael Goldberg, Isabel Gomez-Orellana
Aug 22, 2021·Advanced Drug Delivery Reviews·Sam Maher, David J Brayden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.